EventsThe 1st International Online Conference on Clinical Reports
Published
This submission belongs to the session S3. Cardiovascular Diseases of the event The 1st International Online Conference on Clinical Reports
Published date
17 Mar, 2025
Academic Editor
author-avatarTakatoshi Kasai
Citation
Yohei Tsuchiya, Takao Kato, Eiichiro Sato, HIrokazu Konishi, Ryo Naito, Iwao Okai, Hidemori Hayashi, Tohru Minamino, A case of Euglycemic ketoacidosis in shock vitals during PCI for non-ST elevation myocardial infarction, in Proceedings of The 1st International Online Conference on Clinical Reports, 19 March–20 March 2025, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

A case of Euglycemic ketoacidosis in shock vitals during PCI for non-ST elevation myocardial infarction

Eiichiro Sato 1
HIrokazu Konishi 1
Iwao Okai 1
Tohru Minamino 1
1. Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan, Japan
Abstract

A 77-year-old man, who underwent PCI 11 times in all three branches for unstable angina pectoris and who was taking SGLT2 inhibitor for diabetes mellitus, visited our emergency department because he felt chest strangulation when walking uphill. A 12-lead ECG showed a new ST elevation of more than 0.1 mV at V3~5, and transthoracic echocardiography showed mild hypokinesis in the intermediate posterior wall. Blood tests showed 448 pg/ml of NT-proBNP and that troponin T was slightly elevated at 0.056 mg/ml, leading to a diagnosis of non-ST-segment elevation acute myocardial infarction. The patient was urgently admitted to the hospital with a plan to perform PCI within 24 hours of arrival. After admission, he was prohibited from food intake and started on continuous saline infusion. On the second day, CAG was performed, and 90% stenosis was found in the left coronary artery Seg. 13. During PCI at the same site, the patient went into shock vitals, with urinary ketones 4+ and metabolic acidosis, and was diagnosed with euglycemic diabetic ketoacidosis (EDKA). The acid–base balance was normalized by continuous intravenous small-dose insulin infusion and glucose loading, and the administration of hypertensive drug was terminated on the fifth day of the disease. SGLT2 inhibitors are known to be cardioprotective and renal-protective, and are currently used in many patients. Three days prior to surgery for the withdrawal of SGLT2 inhibitors is recommended, but it is difficult to ensure a sufficient withdrawal period in emergency surgery. There are few case reports of EDKA occurring in this manner, and we report this case with a discussion of the literature.

Keywords
SGLT2 inhibitor
Euglycemic diabetic ketoacidosis
EDKA
PHYSIOTHERAPEUTIC INTERVENTION FOR ACETABULAR FRACTURE IN A 60-YEAR-OLD MALE: A CASE REPORT
Immunotherapy in Thymic carcinoma: Adding quality years to in patients with cancer